A Milwaukee-area location of R3 Stem Cell, a national network offering injection-based and intravenous regenerative treatments for joint, autoimmune, neurological and other conditions.
R3 Stem Cell is a national regenerative medicine network, and this page covers its Milwaukee-area location in Wisconsin. According to the site, R3 works through a network of affiliated centres rather than a single clinic, and it describes more than 80 centres across eight countries. The organisation's chief executive is named on the site as David Greene, MD, PhD, MBA.
The site states that treatment is delivered by injection into a specific joint or area, or given systemically through a drip, depending on what the patient is being treated for. The therapies named include stem cells taken from fat tissue, stem cells taken from bone marrow, umbilical cord derived cells, exosomes (small vesicles released by cells, used as a cell-free preparation), and platelet rich plasma (PRP, prepared from the patient's own blood).
The range of conditions listed on the site is very broad, spanning joint and musculoskeletal problems, autoimmune conditions, heart and circulatory conditions, neurological conditions, and cosmetic or sexual-health concerns such as hair loss and erectile dysfunction. A prospective patient should be aware that regenerative treatments for most of these conditions are not established therapies, and the page does not set out evidence for any individual condition. Anyone considering treatment would need to ask what evidence applies to their own diagnosis.
The page does not name the doctors who would actually see patients at the Milwaukee location, does not give a street address for it, and does not state which cell preparation would be used for a given condition or which laboratory supplies donor-derived cells. These are all things a prospective patient would need to ask directly before booking.
The site lists a wide range of conditions across several unrelated areas of medicine; the following are those named on the page.
The site says it offers several different cell and cell-derived preparations, some taken from the patient's own body and some from donated birth tissue, given either as a targeted injection or through a drip.
The page names the network's chief executive but does not name the clinicians who treat patients at the Milwaukee location.
The Milwaukee entry is a location within the wider R3 Stem Cell network rather than a standalone clinic with its own presence on the site. The page states that R3 has more than 80 centres in eight countries, and treatment at the Wisconsin location is provided through an affiliated centre in the Milwaukee metropolitan area. The page does not give a street address, describe the premises, or say whether any laboratory work is done on site, so a prospective patient would need to contact the network to find out where they would actually be seen.
The site does not publish prices. It says the cost depends on what the patient needs, noting that some patients have a single injection while others need a course of treatment, and it refers to financing being available without giving figures or terms. A prospective patient would have to request a quote, and would be wise to ask what is and is not included before committing.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.